Abbott adds Laralab AI-based cardiac imaging tech

An Abbott (NYSE: ABT)+ official took to social media today to share that the company added Laralab to its portfolio of digital offerings.

Sandra Lesenfants, SVP of Abbott’s Structural Heart division, posted on LinkedIn to share the news of the addition.

“We’re thrilled to welcome Laralab’s talented team to Abbott and together expand the reach of heart.ai —an innovative, cloud-based cardiac imaging technology that empowers clinicians in planning structural heart interventions.”

Abbott — one of the largest medtech companies in the world — did not disclose the details of the deal to add Laralab and its technology.

Sign up for Blog Updates